Luna Laboratory sp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Suspended
Registry date
2016-11-28
Share capital
55,000.00 PLN
Activity description

Luna Laboratory is a Polish medical center based in Łódź that specializes in developing new technologies for the safe use of stem cells in the treatment of multiple sclerosis (MS). They offer a therapy that utilizes autologous stem cells derived from the patient's bone marrow, aiming to halt disease progression and alleviate various MS symptoms. Their unique technology ensures that only beneficial non-hematopoietic stem cells are administered, minimizing the risk of disease transmission and immune rejection.

Registered address
ul. Inwestycyjna 7, 95-050 Konstantynów Łódzki, Poland
Website
Email

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history (in k)

Filing timeliness

4 of 6 financial statements not filed.

  • 202508/07/2026
  • 2024not filed
  • 2023not filed
  • 2022not filed
  • 2021not filed
  • 202017/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Authorized Representatives

Wioletta Jadwiga Zdańska age 47 – President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations of will on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
860$11,615.3478.1818%
229$3,092.9220.8182%
Others
11$148.571%

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2017-12-06 to 2026-07-07.

Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

6 public aid cases recorded, with a total value of $6,850.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,443
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,284
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,516

Competitors

Name
Polimed sp. z o.o.
Royalmed Premium sp. z o.o.
Uzdrowisko Kraków Swoszowice sp. z o.o.
Keymed sp. z o.o.
Celenus sp. z o.o. sp. k.
Medica Komórki Macierzyste sp. z o.o.
IV Clinic sp. z o.o.
Klinika Modic Polska sp. z o.o.
Omedic sp. z o.o.
New Gen sp. z o.o.

Change history

DateEvent
2025-12-31Business suspended
2025-05-27Business resumed
2020-10-01Business suspended
2020-08-31Address change
2019-04-19Share capital increase

FAQ

Last updated: 2026-07-15